Literature DB >> 10203704

Tissue transglutaminase: apoptosis versus autoimmunity.

M Piacentini1, V Colizzi.   

Abstract

Autoimmune diseases are characterized by multiple autoantibodies and/or autoreactive T cells that recognize a large number of antigens. Many of these antigens undergo extensive post-translational modifications during apoptosis and act as substrates for the proapoptotic cystein proteases. Here, Mauro Piacentini and Vittorio Colizzi discuss the effects on autoimmunity produced by post-translational modifications of proteins catalysed by the proapoptotic enzyme tissue transglutaminase.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10203704     DOI： 10.1016/s0167-5699(98)01416-9

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  15 in total

Review 1.  Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances.

Authors:  Swati Gadewar; Alessio Fasano
Journal:  Curr Gastroenterol Rep       Date:  2005-12

2.  Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.

Authors:  Carla Esposito; Monica Marra; Gaia Giuberti; Anna Maria D'Alessandro; Raffaele Porta; Anna Cozzolino; Michele Caraglia; Alberto Abbruzzese
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

3.  Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases.

Authors:  Anastasios E Germenis; Efthalia E Yiannaki; Kalliopi Zachou; Violeta Roka; Sotirios Barbanis; Christos Liaskos; Kalliopi Adam; Andreas N Kapsoritakis; Spyros Potamianos; Georgios N Dalekos
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 4.  Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes.

Authors:  Thomas Delong; Rocky L Baker; Jing He; Kathryn Haskins
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 5.  Dyspepsia and celiac disease: Prevalence, diagnostic tools and therapy.

Authors:  Laura Petrarca; Raffaella Nenna; Gerarda Mastrogiorgio; Matteo Florio; Manuela Brighi; Stefano Pontone
Journal:  World J Methodol       Date:  2014-09-26

Review 6.  Epigenetic histone code and autoimmunity.

Authors:  Jürgen Dieker; Sylviane Muller
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

7.  Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis.

Authors:  P Margutti; F Delunardo; M Sorice; G Valesini; C Alessandri; R Capoano; E Profumo; A Siracusano; B Salvati; R Riganò; E Ortona
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

8.  IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis.

Authors:  N Bizzaro; D Villalta; E Tonutti; A Doria; M Tampoia; D Bassetti; R Tozzoli
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

9.  Gene disruption of tissue transglutaminase.

Authors:  V De Laurenzi; G Melino
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

10.  Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.

Authors:  C Esposito; F Paparo; I Caputo; M Rossi; M Maglio; D Sblattero; T Not; R Porta; S Auricchio; R Marzari; R Troncone
Journal:  Gut       Date:  2002-08       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.